WHITE PAPER
Best practices for Prion detection in tissues and cells
Prions are misfolded proteins believed to be responsible for a wide variety of fatal neurodegenerative diseases. They can either enter the brain through infection or be produced by mutations. In mammals, no current therapies are known to be efficiently stop the propagation of prion aggregates in the nervous system. For this reason characterizing the behavior of prion strains is a crucial step to deepen our understanding of prion diseases. In this White Paper discover how Bertin Instruments supports prion research.
All you need to know about
• Study of the degradation of chronic waste disease prions by humic acids
• Flow cytometry analysis of PrPC Knockdown by si RNA in hDPSCs
• Detection of two prion strains in the spleen and in the granuloma
You may also be interested in
WHITE PAPER
Acylated and Unactylated ghrelin measurement: Application to Metabolic Diseases
WHITE PAPER
Calcitonin gene-related peptide (CGRP) in complex biology matrices: application to pain and inflammation studies
BROCHURE
Discover the Ghrelin ELISA Kits by Bertin Bioreagent
Your expert in life sciences application
